Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma

Cancer Research

Volumn 60, Issue 6, 2000, Pages 1546-1551

  Zannetti, Antonella ^a   Del Vecchio, Silvana ^a   Carriero, Maria V ^b   Fonti, Rosa ^a   Franco, Paola ^c   Botti, Gerardo ^b   D'Aiuto, Giuseppe ^b   Stoppelli, M Patrizia ^c   Salvatore, Marco ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR SP1; UROKINASE; UROKINASE RECEPTOR;

ARTICLE; BREAST CARCINOMA; CANCER INVASION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; BREAST; BREAST NEOPLASMS; DNA-BINDING PROTEINS; FEMALE; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; OLIGONUCLEOTIDES; PROTEIN BINDING; RECEPTORS, CELL SURFACE; SP1 TRANSCRIPTION FACTOR; TUMOR CELLS, CULTURED; UP-REGULATION; URINARY PLASMINOGEN ACTIVATOR;

EID: 0034653737     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Koivunen, E., Arap, W., Valtanen, H., Rainisalo, A., Medina, O. P., Heikkila, P., Kantor, C., Gahmberg, C. G., Salo, T., Konttinen, Y. T., Sorsa, T., Ruoslahti, E., and Pasqualini, R. Tumor targeting with a selective gelatinase inhibitor. Nat. Biotechnol., 17: 768-774, 1999.
2. Blasi, F., and Stoppelli, M. P. Proteases and cancer invasion: from belief to certainty. Biochim. Biophys. Acta, 1423: R35-R44, 1998.
3. Behrendt, N., Ronne, E., Ploug, M., Petri, T., Lober, D., Nielsen, L. S., Schleuning, W., Blasi, F., Appella, E., and Dano, K. The human receptor for urokinase plasminogen activator. J. Biol. Chem., 265: 6453-6460, 1990.
4. Andreasen, P. A., Kjoller, L., Cnristensen, L., and Duffy M. J. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer, 72: 1-22, 1997.
5. Dano, K., Romer, J., Nielsen, B. S., Bjorn, S., Pyke, C., Rygaard, J., and Lund, L. F. Cancer invasion and tissue remodeling-cooperation of protease systems and cell types. APMIS, 107: 120-127, 1999.
6. Del Vecchio, S., Stoppelli, M. P., Carriero, M. V., Fonti, R., Massa, O., Li, P., Botti, G., Cerra, M., D'Aiuto, G., Esposito, G., and Salvatore, M. Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels. Cancer Res., 53: 3198-3206, 1993.
7. Soravia, E., Grebe, A., De Luca, P., Helin, C., Suh, T. T., Dege, J. L., and Blasi, F. A conserved TATA-less proximal promoter drives basal transcription from the urokinase-type plasminogen activator receptor gene. Blood, 86: 624-635, 1995.
8. Allgayer, H., Wang, H., Gallick, G. E., Crabtree, A., Mazar, A., Jones, T., Kraker, A. J., and Boyd, D. Transcriptional induction of the urokinase receptor gene by a constitutively active Src. J. Biol. Chem., 274: 18428-18437, 1999.
9. Lania, L., Majello, B., and De Luca, P. Transcriptional regulation by the Sp family proteins. Int. J. Biochem. Cell Biol., 29: 1313-1323, 1997.
10. Geiser, A. G., Busam, K. J., Kim, S., Lafyatis, R., O'Reilly, M. A., Webbink, R., Roberts, A. B., and Sporn, M. B. Regulation of the transforming growth factor-β1 and -β3 promoters by transcription factor Sp1. Gene. 129: 223-228, 1993.
11. Araki, E., Murakami, T., Shirotani, T., Kanai, F., Shinohara, Y., Shimada, F., Mori, M., Shichiri, M., and Ebina, Y. A cluster of four Sp1 binding sites required for efficient expression of the human insulin receptor gene. J. Biol. Chem., 266: 3944-3948, 1991.
12. Borellini, F., He, Y. F., Aquino, A., Yu, G., Joseph, S. F., and Glazer, R. I. Increased DNA binding and trancriptional activity associated with transcription factor Sp1 in K562 cells transfected with the myeloid-specific c-fes tyrosine kinase gene. J. Biol. Chem., 266: 15850-15854, 1991.
13. Kim, S., Onwuta, U. S., Lee, Y. I., Li, R., Botchan, M. R., and Robbins, P. D. The retinoblastoma gene product regulates Sp1-mediated transcription. Mol. Cell. Biol., 12: 2455-2463, 1992.
14. Sif, S., Capobianco, A. J., and Gilmore, T. D. The v-Rel oncoprotein increases expression from Sp1 site-containing promoters in chicken embryo fibroblasts. Oncogene, 8: 2501-2509, 1993.
15. Armstrong, S. A., Barry, D. A., Legget, R. W., and Mueller, C. R. Casein kinase II-mediated phosphorylation of the C terminus of Sp1 decreases its DNA binding activity. J. Biol. Chem., 272: 13489-13495, 1997.
16. Daniel, S., Zhang, S., DePaoli-Roach, A. A., and Kim, K. Dephosphorylation of Sp1 by protein phosphatase 1 is involved in the glucose-mediated activation of the acetyl-CoA carboxylase gene. J. Biol. Chem., 271: 14692-14697, 1996.
17. Merchant, J. L., Shiotani, A., Mortensen, E. R., Shumaker, D. K., and Abraczinskas. D. R. Epidermal growth factor stimulation of the human gastrin promoter requires Sp1. J. Biol. Chem., 270: 6314-6319, 1995.
18. INK4B through an Sp1 consensus site. J. Biol. Chem., 270: 26750-26753, 1995.
19. Kitadai, Y., Yasui, W., Yokozaki, H., Kuniyasu, H., Haruma, K, Kajiyama, G., and Tahara, E. The level of a transcription factor Sp1 is correlated with the expression of EGF receptor in human gastric carcinomas. Biochem. Biophys. Res. Commun., 189: 1342-1348, 1992.
20. Lietard, J., Musso, O., Theret, N., L' Helgoualc'h, A., Campion, J. P., Yamada, Y., and Clement, B. Sp1-mediated transactivation of LamC1 promoter and coordinated expression of laminin-γ1 and Sp1 in human hepatocellular carcinomas. Am. J. Pathol., 151: 1663-1671, 1997.
21. Blume, S. W., Snyder, R. C., Ray, A., Thomas, S., Koller, C. A., and Miller, D. M. Mithramycin inhibits Sp1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J. Clin. Invest., 88: 1613-1621, 1991.
22. Dignam, J. D., Lebovitz, R. M., and Roeder, R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res., 11: 1475-1489, 1983.
23. 5 vitronectin receptor promoting urokinase-dependent cell migration in breast cancer. Cancer Res., 59: 5307-5314, 1999.
24. Carriero, M. V., Del Vecchio, S., Franco, P., Potena, M. I., Chiaradonna, F., Botti, G., Stoppelli, M. P., and Salvatore, M. Vitronectin binding to urokinase receptor in human breast cancer. Clin. Cancer Res., 3: 1299-1308, 1997.
25. Blasi, F. Surface receptors for urokinase plasminogen activator. Fibrinolysis, 2: 73-84, 1988.
26. Carriero, M. V., Franco, P., Del Vecchio, S., Massa, O., Botti, G., D'Aiuto, G., Stoppelli, M. P., and Salvatore, M. Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies. Cancer Res., 54: 5445-5454, 1994.
27. Look, M. P., and Foekens, J. Clinical relevance of the urokinase plasminogen activator system in breast cancer. APMIS, 107: 150-159, 1999.
28. Stephens, R. W., Nielsen, H. J., Christensen, I. J., Thorlacius-Ussing, Sorensen, S., Dano, K., and Brunner, N. Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis. J. Natl. Cancer Inst., 91: 869-874, 1999.
29. Lund, R. L., Ellis, V., Ronne, E., Pyke, C., and Dano, K. Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell line A549. Biochem. J., 310: 345-352, 1995.
30. Johnson, M. D., Torri, J. A., Lippman, M. E., and Dickson, R. B. Regulation of motility and protease expression in PKC-mediated induction of MCF-7 breast cancer cell invasiveness. Exp. Cell Res., 247: 195-113, 1999.
31. Shetty, S., Kumar, A., and Idell, S. Posttranscriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mesotheliam cells. Mol. Cell. Biol., 17: 1075-1083, 1997.
32. Gum, R., Juarez, J., Allgayer, H., Mazar, A., Wang, Y., and Boyd, D. Stimulation of urokinase-type plasminogen activator receptor expression by PMA requires JNK1-dependent and -independent signaling modules. Oncogene, 17: 213-225, 1998.
33. Allgayer, H., Wang, H., Wang, Y., Heiss, M. M., Bauer, R., Nyormoi, O., and Boyd, D. Transactivation of the urokinase-type plasminogen activator receptor gene through a novel promoter motif bound with an activator protein-2α-related factor. J. Biol. Chem., 274: 4702-4714, 1999.
34. Resnati, M., Guttinger, M., Valcamonica, S., Sidenius, N., Basi, F., and Fazioli, F. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. EMBO J., 15: 1572-1582, 1996.
35. hck activation state is a molecular switch between myelomonocytic cell motility and adherence. EMBO J., 18: 3013-3023, 1999.
36. Konakova, M., Hucho, F., and Schleuning, W. D. Downstream targets of urokinase-type plasminogen-activator-mediated signal transduction. Eur. J. Biochem., 253: 421-429, 1998.
37. Nehls, M. C., Brenner, D. A., Gruss, H., Dierbach, H., Mertelsmann, R., and Hermann, F. Mithramycin selectively inhibits collagen-α1 (I) gene expression in human fibroblast. J. Clin. Invest., 92: 2916-2921, 1993.
38. Chisholm, M. A., Mulloy, A. L., and Taylor, A. T. Acute management of cancer-related hypercalcemia. Ann. Pharmacother., 30: 507-513, 1996.
39. Kroon, M. E., Koolwijk, P., van Goor, H., Weidle, U. H., Collen, A., van der Pluijm, G., and van Hinsbergh, V. W. Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices. Am. J. Pathol., 154: 1731-1742, 1999.
40. Brower, V. Tumor angiogenesis-new drugs on the block. Nat. Biotechnol., 17: 963-968, 1999.
41. Ryuto, M., Ono, M., Izumi, H., Yoshida, S., Weich, H. A., Kohno, K., and Kuwano, M. Induction of vascular endothelial growth factor hy tumor necrosis factor α in human glioma cells. J. Biol. Chem., 271: 28220-28228, 1996.
42. Giraudo, E., Primo, L., Audero, E., Gerber, H. P., Koolwijk, P., Soker, S., Klagsbrun, M., Ferrara, N., and Bussolino, F. Tumor necrosis factor-α regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells. J. Biol. Chem., 273: 22128-22135, 1998.